OL

Olema

San Francisco, US · 3 known investors

olema.com ↗

Olema is a clinical-stage biopharmaceutical company developing novel therapies for metastatic breast cancer and other endocrine-driven cancers, targeting nuclear receptors and mechanisms of acquired resistance. It focuses on improving treatment outcomes for patients living with breast cancer.

Investors · 3

AV

Avoro Capital AdvisorsNew York

LI

Lightspeed Venture PartnersMenlo Park · $1.7M – $87M

RA

RA CapitalBoston